Lale Kostakoglu-Shields, MD (Nuclear Medicine)Professor of Radiology and Medical Imaging
Director of Nuclear Medicine and Molecular Imaging
Dr. Kostakoglu is a recognized leader in the use of molecular imaging with positron emission tomography/computed tomography (PET/CT), which provides a detailed look at what is happening in the body at the cellular level. She is also well regarded for her expertise in the radionuclide treatment of various cancers.
She has had a longstanding interest in evaluating patient response to cancer. Her research interests include investigating new radiopharmaceutical therapies of cancer directed by molecular imaging, and ways to integrate them into an individualized cancer management plan. Dr. Kostakoglu sees a wide range of patients from oncology, cardiology and neurology, among other specialties.
Dr. Kostakoglu is responsible for both PRRT, peptide receptor radionuclide therapy, and Gallium-68 nuclear imaging of neuroendocrine tumor patients.
Listen to Dr. Kostakoglu speak about peptide receptor radionuclide therapy or PRRT with Lutathera for neuroendocrine tumor patients: